Kwok Pang, COO, Autolomous, London, UK, explains the challenges involved with integrating electronic software solutions for the management of critical manufacturing data for cell and gene therapies into healthcare systems. He describes an initiative that aims to develop and implement a UK NHS-owned digital system that integrates with manufacturer software in order to enhance the management of patient data, clinical samples and the ordering of advanced therapies by the NHS. He highlights the need for uniformity across the sector in the technologies, standards and methods used for information exchange. This interview took place at the Advanced Therapies Congress & Expo 2021.